Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection

Clinical trial NCT01897831 · UNKNOWN

Trial details

NCT number: NCT01897831
Sponsor: Xiangbei Welman Pharmaceutical Co., Ltd
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Respiratory Tract Infections Urinary Tract Infections

Start date: 2011-08-01
Primary completion: 2015-08-01
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.